Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis.

[1]  M. Kirkland,et al.  A phase space model of hemopoiesis and the concept of stem cell renewal. , 2004, Experimental hematology.

[2]  J. Kutok,et al.  Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1 , 2004, Nature Genetics.

[3]  T. Graf,et al.  Stepwise Reprogramming of B Cells into Macrophages , 2004, Cell.

[4]  A. Riggs,et al.  Dynamic reorganization of chromatin structure and selective DNA demethylation prior to stable enhancer complex formation during differentiation of primary hematopoietic cells in vitro. , 2004, Blood.

[5]  S. Ogawa,et al.  AML1 Is Functionally Regulated through p300-mediated Acetylation on Specific Lysine Residues* , 2004, Journal of Biological Chemistry.

[6]  D. Gilliland,et al.  Genetics of myeloid leukemias. , 2003, Annual review of genomics and human genetics.

[7]  D. Krause,et al.  Plasticity of marrow-derived stem cells. , 2003, Blood.

[8]  K. Akashi,et al.  Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. , 2003, Immunity.

[9]  M. Busslinger,et al.  Myeloid lineage switch of Pax5 mutant but not wild‐type B cell progenitors by C/EBPα and GATA factors , 2003, The EMBO journal.

[10]  E. Selker,et al.  Structural basis for the product specificity of histone lysine methyltransferases. , 2003, Molecular cell.

[11]  J. Cowland,et al.  The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. , 2003, Blood.

[12]  K. Akashi,et al.  Enforced Granulocyte/Macrophage Colony-stimulating Factor Signals Do Not Support Lymphopoiesis, but Instruct Lymphoid to Myelomonocytic Lineage Conversion , 2003, The Journal of experimental medicine.

[13]  T. Lister,et al.  Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2 , 2003, Genes, chromosomes & cancer.

[14]  Bruce E. Torbett,et al.  Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1 , 2003 .

[15]  K. Klempnauer,et al.  Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity , 2003, The EMBO journal.

[16]  Daniel G. Tenen,et al.  Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.

[17]  J. Downing.  The core-binding factor leukemias: lessons learned from murine models. , 2003, Current opinion in genetics & development.

[18]  Toshiyuki Yamada,et al.  Molecular biology of the Ets family of transcription factors. , 2003, Gene.

[19]  P. Quesenberry,et al.  The chiaroscuro stem cell: a unified stem cell theory. , 2002, Blood.

[20]  Stuart L. Schreiber,et al.  Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.

[21]  John T. Dimos,et al.  A Stem Cell Molecular Signature , 2002, Science.

[22]  Tariq Enver,et al.  Transcription factor‐mediated lineage switching reveals plasticity in primary committed progenitor cells , 2002, The EMBO journal.

[23]  M. Busslinger,et al.  Reversion of B Cell Commitment upon Loss of Pax5 Expression , 2002, Science.

[24]  J. Licht,et al.  Histone deacetylases as therapeutic targets in hematologic malignancies. , 2002, Current opinion in hematology.

[25]  Min Ye,et al.  Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. , 2002, Developmental cell.

[26]  K. Akashi,et al.  Induction of granulocytic differentiation by 2 pathways. , 2002, Blood.

[27]  A. D. Panopoulos,et al.  Control of Myeloid-specific Integrin αMβ2 (CD11b/CD18) Expression by Cytokines Is Regulated by Stat3-dependent Activation of PU.1* , 2002, The Journal of Biological Chemistry.

[28]  A. Friedman.  Transcriptional regulation of granulocyte and monocyte development , 2002, Oncogene.

[29]  Jiang Zhu,et al.  Hematopoietic cytokines, transcription factors and lineage commitment , 2002, Oncogene.

[30]  J. Aster,et al.  An Invitation to T and More Notch Signaling in Lymphopoiesis , 2002, Cell.

[31]  A. Friedman,et al.  CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor. , 2002, Blood.

[32]  Carl W. Miller,et al.  Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. , 2002, Blood.

[33]  D. Skalnik.  Transcriptional mechanisms regulating myeloid-specific genes. , 2002, Gene.

[34]  C. Bonifer,et al.  Identification of factors mediating the developmental regulation of the early acting -3.9 kb chicken lysozyme enhancer element. , 2001, Nucleic acids research.

[35]  S. Collins,et al.  Multipotent hematopoietic cell lines derived from C/EBPalpha(-/-) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte- colony-stimulating factor, and retinoic acid-induced granulocytic differentiation. , 2001, Blood.

[36]  J. Whitsett,et al.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. , 2001, Immunity.

[37]  H. Nakajima,et al.  Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein epsilon. , 2001, Blood.

[38]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[39]  Hong Sun,et al.  C/EBPɛ mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  I. Touw,et al.  C/EBPα and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes , 2001, Leukemia.

[41]  T. Shirai,et al.  Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. , 2001, Blood.

[42]  M. Trevisan,et al.  Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. , 2001, Blood.

[43]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[44]  S. Orkin,et al.  PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. , 2000, Blood.

[45]  I. Weissman,et al.  Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines , 2000, Nature.

[46]  A. Riggs,et al.  Chromatin fine structure profiles for a developmentally regulated gene: reorganization of the lysozyme locus before trans-activator binding and gene expression. , 2000, Genes & development.

[47]  A. Leutz,et al.  Translational control of C/EBPalpha and C/EBPbeta isoform expression. , 2000, Genes & development.

[48]  S. Bartelmez,et al.  Mouse Jagged2 is differentially expressed in hematopoietic progenitors and endothelial cells and promotes the survival and proliferation of hematopoietic progenitors by direct cell-to-cell contact. , 2000, Blood.

[49]  T. Zibello,et al.  Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation. , 2000, Blood.

[50]  G C Overton,et al.  The genetic program of hematopoietic stem cells. , 2000, Science.

[51]  H. Singh,et al.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1. , 2000, Science.

[52]  E. Querfurth,et al.  GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. , 2000, Blood.

[53]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[54]  G. Blobel.  CREB-binding protein and p300: molecular integrators of hematopoietic transcription. , 2000, Blood.

[55]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[56]  Elaine Fuchs,et al.  Stem Cells A New Lease on Life , 2000, Cell.

[57]  Stephen L. Nutt,et al.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 , 1999, Nature.

[58]  Dong-er Zhang,et al.  CCAAT/Enhancer-binding Protein Activates the CD14 Promoter and Mediates Transforming Growth Factor β Signaling in Monocyte Development* , 1999, The Journal of Biological Chemistry.

[59]  A. E. Sippel,et al.  Differential activity of the -2.7 kb chicken lysozyme enhancer in macrophages of different ontogenic origins is regulated by C/EBP and PU.1 transcription factors. , 1999, DNA and cell biology.

[60]  D. Tenen,et al.  Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Steven M. Holland,et al.  Neutrophil-specific Granule Deficiency Results from a Novel Mutation with Loss of Function of the Transcription Factor CCAAT/Enhancer Binding Protein ε , 1999, The Journal of experimental medicine.

[62]  N. Rekhtman,et al.  Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. , 1999, Genes & development.

[63]  Jia Liu,et al.  Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Chumakov,et al.  C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. , 1999, Blood.

[65]  W. Miller,et al.  CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. , 1999, The Journal of clinical investigation.

[66]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[67]  S. Mckercher,et al.  Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1. , 1999, Blood.

[68]  Daniel G. Tenen,et al.  c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor* , 1999, The Journal of Biological Chemistry.

[69]  Pu Zhang,et al.  Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha (C/EBP alpha) is critical for granulopoiesis. , 1998 .

[70]  F. Pio,et al.  Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. , 1998, Blood.

[71]  J. Walsh,et al.  PU.1 regulates both cytokine‐dependent proliferation and differentiation of granulocyte/macrophage progenitors , 1998, The EMBO journal.

[72]  T. Graf,et al.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. , 1998, Genes & development.

[73]  T. Graf,et al.  Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. , 1998, Genes & development.

[74]  T. Enver,et al.  Do stem cells play dice? , 1998, Blood.

[75]  D. Metcalf.  Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. , 1998, Blood.

[76]  D. Tenen,et al.  CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.

[77]  S. Mckercher,et al.  Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha. , 1998, Nucleic acids research.

[78]  L. Iacopino,et al.  Identification by Differential Display of Transcripts Regulated during Hematopoietic Differentiation , 1998, Stem cells.

[79]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[80]  J. Downing,et al.  The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation , 1998, Molecular and Cellular Biology.

[81]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .

[82]  A. Sharrocks,et al.  The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.

[83]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[84]  C. Barlow,et al.  Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[85]  D. Housman,et al.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[86]  C. Tribioli,et al.  Acute leukemia with promyelocytic features in PML/RARα transgenic mice , 1997 .

[87]  I. Weissman,et al.  A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .

[88]  M. Greaves,et al.  Multilineage gene expression precedes commitment in the hemopoietic system. , 1997, Genes & development.

[89]  D. Tenen,et al.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[90]  T. Ley,et al.  Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. , 1997, Blood.

[91]  C. Wijmenga,et al.  Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.

[92]  F. Alt,et al.  The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.

[93]  D. Tenen,et al.  Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[94]  S. Mckercher,et al.  PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. , 1996, Blood.

[95]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[96]  D. Tenen,et al.  PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. , 1996, Blood.

[97]  A. Friedman.  GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. , 1996, Cancer research.

[98]  Cameron S. Osborne,et al.  Regulation of GM-CSF gene transcription by core-binding factor. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[99]  R. Yamanaka,et al.  A Novel Human CCAAT/Enhancer Binding Protein Gene, C/EBPϵ, Is Expressed in Cells of Lymphoid and Myeloid Lineages and Is Localized on Chromosome 14q11.2 Close to the T-Cell Receptor α/δ Locus , 1996 .

[100]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[101]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Kodandapani,et al.  A new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex , 1996, Nature.

[103]  D. Tenen,et al.  CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter , 1996, Molecular and cellular biology.

[104]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[105]  L. McIntosh,et al.  Solution structure of the ETS domain from murine Ets‐1: a winged helix‐turn‐helix DNA binding motif. , 1996, The EMBO journal.

[106]  E. Scott,et al.  PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. , 1995, Immunity.

[107]  T. Graf,et al.  NF‐M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. , 1995, The EMBO journal.

[108]  A. Gronenborn,et al.  The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation , 1995, Cell.

[109]  D. Tenen,et al.  PU.1 (Spi-1) autoregulates its expression in myeloid cells. , 1995, Oncogene.

[110]  D. Tenen,et al.  PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene , 1995, Molecular and cellular biology.

[111]  K. Arai,et al.  Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. , 1995, Blood.

[112]  U. Storb,et al.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. , 1995, Genes & development.

[113]  C. Glass,et al.  Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. , 1995, Blood.

[114]  T. Graf,et al.  GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. , 1995, Genes & development.

[115]  R. Cortese,et al.  Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.

[116]  A. Rosmarin,et al.  CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Nobuaki Yoshida,et al.  Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.

[118]  C. J. Barnett,et al.  Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes , 1994, The Journal of experimental medicine.

[119]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[120]  S Meyers,et al.  PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells , 1994, Molecular and cellular biology.

[121]  A. Sartorelli,et al.  Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-jun. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[122]  M. Birrer,et al.  Constitutive cJun expression induces partial macrophage differentiation in U-937 cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[123]  M. Klemsz,et al.  Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. , 1993, Blood.

[124]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[125]  S. Collins,et al.  A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[126]  A. Friedman,et al.  The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1) , 1993, Molecular and cellular biology.

[127]  R. Maki,et al.  The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. , 1993, The Journal of biological chemistry.

[128]  D. Liebermann,et al.  Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation , 1993, Molecular and cellular biology.

[129]  D. Tenen,et al.  The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor , 1993, Molecular and cellular biology.

[130]  H. Drabkin,et al.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.

[131]  P. Rørth,et al.  A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. , 1992, Blood.

[132]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[133]  U. Schibler,et al.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA , 1991, Cell.

[134]  S. Orkin,et al.  Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. , 1991, Genes & development.

[135]  N. Copeland,et al.  Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. , 1991, Development.

[136]  C. Kozak,et al.  The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1 , 1991, Journal of virology.

[137]  Manoel Luis Costa,et al.  MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[138]  S. McKnight,et al.  Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. , 1990, Genes & development.

[139]  C. Sherr,et al.  Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes , 1990, Molecular and cellular biology.

[140]  M. Klemsz,et al.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene , 1990, Cell.

[141]  M. Mattei,et al.  The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. , 1989, Oncogene.

[142]  S. McKnight,et al.  CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. , 1989, Genes & development.

[143]  S. McKnight,et al.  The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. , 1989, Science.

[144]  C. Bunce,et al.  The development of cell lineages: a sequential model. , 1988, Differentiation; research in biological diversity.

[145]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[146]  W. Alexander,et al.  Hemopoietic lineage switch: v-raf oncogene converts Eμmyc transgenic B cells into macrophages , 1988, Cell.

[147]  Harold Weintraub,et al.  Transfection of a DNA locus that mediates the conversion of 10T1 2 fibroblasts to myoblasts , 1986, Cell.

[148]  D. Leprince,et al.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26 , 1983, Nature.

[149]  P. Seeburg,et al.  Tripartite structure of the avian erythroblastosis virus E26 transforming gene , 1983, Nature.

[150]  J. W. Schrader,et al.  Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine , 1982, Nature.

[151]  P. Quesenberry,et al.  Stem cell plasticity: an overview. , 2004, Blood cells, molecules & diseases.

[152]  Articles on similar topics can be found in the following Blood collections Cell Adhesion and Motility (790 articles) , 2003 .

[153]  P. Gaines,et al.  Retinoids in myelopoiesis. , 2003, Journal of biological regulators and homeostatic agents.

[154]  D. Tenen,et al.  The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. , 2003, Blood.

[155]  Michael Cross,et al.  Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. , 2003, Experimental hematology.

[156]  M. Minden,et al.  Heterozygous PU.1 mutations are associated with acute myeloid leukemia. , 2002, Blood.

[157]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[158]  C. Sawyers,et al.  C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. , 1999, Blood.

[159]  N. Nicola,et al.  The Hemopoietic Colony-Stimulating Factors: Actions of the colony-stimulating factors in vivo , 1995 .

[160]  B. Wasylyk,et al.  The Ets family of transcription factors. , 1993, European journal of biochemistry.